BRIEF published on 01/21/2025 at 21:05, 1 year 2 months ago Fundraising of €0.25 million by Néovacs Fundraising Shareholder Dilution Néovacs OCEANE-BSA Kinoid® Research
BRIEF published on 01/21/2025 at 21:05, 1 year 2 months ago Levée de fonds de 0,25 M€ par Néovacs Levée De Fonds Néovacs OCEANE-BSA Dilution Actionnaire Recherche Kinoïde®
PRESS RELEASE published on 01/21/2025 at 21:00, 1 year 2 months ago Levée de fonds de 0,25 MEUR Néovacs annonce une levée de fonds de 0,25 M€ par l'émission d'OCEANE-BSA pour financer la recherche sur les allergies et les investissements en BioTech et MedTech Biotech MedTech Levée De Fonds Néovacs OCEANE-BSA
BRIEF published on 01/15/2025 at 20:05, 1 year 2 months ago Adjustment of the nominal value at Neovacs Investment Capital Reduction Nominal Value Néovacs Stock Market Shares
BRIEF published on 01/15/2025 at 20:05, 1 year 2 months ago Ajustement de la valeur nominale chez Néovacs Investissement Valeur Nominale Néovacs Actions Boursières Réduction Capital
PRESS RELEASE published on 01/15/2025 at 20:00, 1 year 2 months ago Ajustement de la valeur nominale Néovacs réduit la valeur nominale de son action de 1 euro à 0,50 euro, suite à une réduction de capital motivée par des pertes. La société française développe des thérapies pour maladies inflammatoires Biopharmaceutique Réduction De Capital Maladies Inflammatoires Valeur Nominale Néovacs
BRIEF published on 12/18/2024 at 08:35, 1 year 3 months ago Levée de fonds par Néovacs Biotechnologie Levée De Fonds Dilution Néovacs OCEANE-BSA
BRIEF published on 12/18/2024 at 08:35, 1 year 3 months ago Fundraising by Neovacs Biotechnology Fundraising Dilution Néovacs OCEANE-BSA
PRESS RELEASE published on 12/18/2024 at 08:30, 1 year 3 months ago Levée de fonds de 0,25 MEUR Néovacs annonce une levée de fonds de 0,25 M€ pour financer le programme de recherche Kinoïde® sur les allergies et renforcer les investissements en BioTech et MedTech Biotech Levée De Fonds Néovacs Kinoïde® Allergies
BRIEF published on 09/18/2024 at 20:05, 1 year 6 months ago Fundraising of €0.25 million by Néovacs Biotechnology Fundraising Investment Dilution OCEANE-BSA
Published on 03/27/2026 at 15:35, 37 minutes ago SouthGobi Announces Fourth Quarter and Full Year 2025 Financial and Operating Results
Published on 03/27/2026 at 12:30, 3 hours 42 minutes ago Pasinex Closes First Tranche of Over-Subscribed Non-Brokered Private Placement
Published on 03/27/2026 at 12:00, 4 hours 12 minutes ago Temas Appoints Scientific Advisory Board to Accelerate RCL Commercialisation and Global Development
Published on 03/27/2026 at 11:00, 5 hours 12 minutes ago RE Royalties Announces Strategic Review to Evaluate Path for Long-Term Value Creation
Published on 03/27/2026 at 15:58, 14 minutes ago coinIX remains resilient in volatile market environment with balanced annual result | CEO Moritz Schildt sees entry-level prices in the crypto market
Published on 03/27/2026 at 15:50, 22 minutes ago EQS-Adhoc: Klöckner & Co SE: Worthington Steel announces intention to enter into a domination and profit and loss transfer agreement with Klöckner & Co SE
Published on 03/27/2026 at 15:05, 1 hour 7 minutes ago Huawei's 6th Global Installer Summit: Gathering the Best Installers to Embrace Renewable Energy Opportunities in the AI Era
Published on 03/27/2026 at 14:31, 1 hour 41 minutes ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Published on 03/27/2026 at 07:00, 9 hours 12 minutes ago WEB SA - CONVOCATION ASSEMBLEE GENERALE ORDINAIRE EXERCICE 2025 - 28/04/2026
Published on 03/26/2026 at 18:17, 21 hours 55 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 21 hours 55 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 22 hours 12 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
